Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
20.01.25
09:43 Uhr
3,180 Euro
+0,025
+0,79 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
3,1603,24021.01.

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.01.Implantica announces new exceptional published data from the largest real-world study from Germany341VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
23.12.24Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration10
23.12.24Implantica to be included in Nasdaq's First North 25 index360VADUZ, Liechtenstein, Dec. 23, 2024 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
19.12.24Implantica strengthens the strategic RefluxStop expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline329VADUZ, Liechtenstein, Dec. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
18.12.24Implantica announces two new RefluxStop University Hospitals in Spain, leading to 10 active centers and many more to join soon339VADUZ, Liechtenstein, Dec. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
17.12.24Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop Center of Excellence and several lined up to start near-term410VADUZ, Liechtenstein, Dec. 17, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
15.11.24Implantica publishes Interim Report January - September 2024 (Q3)398VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ -- RefluxStop achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the...
► Artikel lesen
14.11.24Implantica submits FDA PMA application Clinical Module 2 for RefluxStop for U.S. market approval320VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
08.11.24Implantica presents the third quarter 2024 on November 15 at 15:00 CEST318VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the...
► Artikel lesen
10.10.24Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop received remarkable pre-launch market feedback366VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive...
► Artikel lesen
10.10.24Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback4
01.10.24Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch297VADUZ, Liechtenstein, Oct. 1, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that the first Spanish...
► Artikel lesen
25.09.24Implantica shares a landmark review article on standard of care Nissen Fundoplication anti-reflux surgery - in light of the recently announced excellent RefluxStop 5-year results397VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
25.09.24Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop297VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
19.09.24Implantica conducts first national RefluxStop User meeting with 21 participating surgeons, 1.5 years after launch in Italy443VADUZ, Liechtenstein, Sept. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, had the pleasure to host a...
► Artikel lesen
18.09.24Implantica announces excellent data from an independent study of 158 RefluxStop patients from two centers in Germany - presented at the AUGIS meeting in UK465VADUZ, Liechtenstein, Sept. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports that the study "Pooled...
► Artikel lesen
11.09.24Implantica mourns the death of board member Prof. Dr. Klaus Neftel8
21.08.24Implantica publishes Interim Report January - June 2024 (Q2)593VADUZ, Liechtenstein, Aug. 21, 2024 /PRNewswire/ -- RefluxStop is on a wave of success - carried by a multitude of published studies with excellent outcomes from leading European Reflux-centers Significant...
► Artikel lesen
20.08.24Implantica announces RefluxStop pivotal 4-year study results published in the prestigious journal Surgical Endoscopy447VADUZ, Liechtenstein, Aug. 20, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces excellent long-term...
► Artikel lesen
15.08.24Implantica announces another landmark real-world RefluxStop study demonstrating excellent outcomes published in a prestigious top-tier journal332VADUZ, Liechtenstein, Aug. 15, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone...
► Artikel lesen
Seite:  Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1